Mesenchymal stromal cells as first-line treatment of graft failure after hematopoietic stem cell transplantation.
Ringdén
Olle
O
D006084:Graft Rejection / Q000517:prevention & control; D006410:Hematopoiesis; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007938:Leukemia / Q000097:blood / Q000628:therapy; D045164:Mesenchymal Stem Cell Transplantation / Q000379:methods*; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000628:therapy; D020127:Recovery of Function; D012074:Remission Induction; D017154:Stromal Cells / Q000166:cytology / Q000637:transplantation*; D013997:Time Factors; D019172:Transplantation Conditioning / Q000379:methods*; D014184:Transplantation, Homologous; D016896:Treatment Outcome